357262-90-9

Basic information

• Product Name: 4-BENZOYL-2-METHYL-1-[(7-OXIDO-1H-PYRROLO[2,3-B] PYRIDIN-3-YL)OXOACETYL]-PIPERAZINE
• Synonyms: 4-BENZOYL-2-METHYL-1-[(7-OXIDO-1H-PYRROLO[2,3-B] PYRIDIN-3-YL)OXOACETYL]-PIPERAZINE;4-Benzoyl-2-methyl-1-[(7-oxido-1H-pyrroli[2,3-b]pyridin-3-yl)oxoacetyl]-piperazine;4(R)-3-(2-(4-BENZOYL-2-METHYLPIPERAZIN-1-YL)-2-OXOACETYL)-1H-PYRROLO[2,3-B]PYRIDINE 7-OXIDE;BMS-378806 DERIVATIVE / 4-BENZOYL-2-METHYL-1-[(7-OXIDO-1H-PYRROLO[2,3-B] PYRIDIN-3-YL)OXOACETYL]-PIPERAZINE;(R)-4-Benzoyl-2-Methyl-1-[3-(7-azaindole)oxoacetyl] piperazine
• CAS NO: 357262-90-9
• Molecular Formula: C₂₁H₂₀N₄O₄
• Molecular Weight: 392.41
• Mol File: 357262-90-9.mol
• Article Data: 3

Chemical Properties

• Boiling Point: °Cat760mmHg
• Flash Point: °C
• Appearance: /
• Density: g/cm³
• CAS DataBase Reference: 4-BENZOYL-2-METHYL-1-[(7-OXIDO-1H-PYRROLO[2,3-B] PYRIDIN-3-YL)OXOACETYL]-PIPERAZINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BENZOYL-2-METHYL-1-[(7-OXIDO-1H-PYRROLO[2,3-B] PYRIDIN-3-YL)OXOACETYL]-PIPERAZINE(357262-90-9)
• EPA Substance Registry System: 4-BENZOYL-2-METHYL-1-[(7-OXIDO-1H-PYRROLO[2,3-B] PYRIDIN-3-YL)OXOACETYL]-PIPERAZINE(357262-90-9)

Safety Data

• Hazardous Substances Data: 357262-90-9(Hazardous Substances Data)

Usage

General Description

4-BENZOYL-2-METHYL-1-[(7-OXIDO-1H-PYRROLO[2,3-B] PYRIDIN-3-YL)OXOACETYL]-PIPERAZINE is a chemical compound with a complex molecular structure. It contains a piperazine ring with a benzoate and methyl group attached, as well as a pyrrole and pyridine ring fused together. The compound also contains an oxoacetyl group and an oxidized pyrrolo ring. This chemical is likely to have pharmaceutical or medicinal applications due to its complex structure and potential for interacting with biological systems. It may also have uses in research and development of new drugs.

InChI:InChI=1/C21H20N4O4/c1-14-13-23(20(27)15-6-3-2-4-7-15)10-11-24(14)21(28)18(26)17-12-22-19-16(17)8-5-9-25(19)29/h2-9,12,14,22H,10-11,13H2,1H3/t14-/m1/s1

Upstream product

• 357263-39-9 1-benzoyl-3-(R)-methylpiperazine 
• 357263-49-1 methyl α-oxo-1H-pyrrolo[2,3-b]pyridine-3-acetate 
• 75336-86-6 (2R)-methylpiperazine 
• 271-63-6 7-Azaindole 
• 93-58-3 benzoic acid methyl ester 
• 357262-60-3 (R)-1-(4-benzoyl-2-methylpiperazin-1-yl)-2-(1H-pyrrolo[2,3-b]pyridin-3-yl)ethane-1,2-dione 

Downstream Products

• 357263-05-9 4-benzoyl-1-[(4-methoxy-7-oxido-1H-pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2-(R)-methylpiperazine 
• 357263-13-9 4-benzoyl-1-[(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2-(R)-methylpiperazine 
• 357262-96-5 4-benzoyl-2-(R)-methyl-1-[(4-nitro-7-oxido-1H-pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]piperazine 

Relevant articles and documents

TARGETED BIFUNCTIONAL DEGRADERS

The present invention provides, in one aspect, bifunctional compounds that can be used to promote or enhance degradation of certain circulating proteins. In another aspect, the present invention provides bifunctional compounds that can be used to promote or enhance degradation of certain autoantibodies. In certain embodiments, treatment or management of a disease and/or disorder requires degradation, removal, or reduction in concentration of the circulating protein or the autoantibody in the subject. Thus, in certain embodiments, administration of a compound of the invention to the subject removes or reduces the circulation concentration of the circulating protein or the autoantibody, thus treating, ameliorating, or preventing the disease and/or disorder. In certain embodiments, the circulating protein is TNF.

Discovery of 4-benzoyl-1-[(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2-(R) -methylpiperazine (BMS-378806): A novel HIV-1 attachment inhibitor that interferes with CD4-gp120 interactions

Indole derivative 1 interferes with the interaction of the HIV surface protein gp120 with the host cell receptor CD4. The 4-fluoro derivative 2 exhibited markedly enhanced potency and was bioavailable in the rat, dog, and cynomolgus monkey when administered orally as a solution formulation. However, aqueous suspensions of 2 were poorly bioavailable, indicative of dissolution-limited absorption. The 7-azaindole derivative 3, BMS-378806, exhibited improved pharmaceutical properties while retaining the HIV-1 inhibitory profile of 2.